NCT01921010View on ClinicalTrials.gov

Benefit of Elevation of HDL-C in Women

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Cardiovascular Outcomes
Interventions
DRUG

Niaspan

See Arm Description

DRUG

Placebo

See Arm Description

Trial Locations (1)

90048

Cedars-Sinai Medical Center, Los Angeles

All Listed Sponsors
lead

Cedars-Sinai Medical Center

OTHER

NCT01921010 - Benefit of Elevation of HDL-C in Women | Biotech Hunter | Biotech Hunter